{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:48:12Z","timestamp":1795225692346,"version":"4.10.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obsessive-Compulsive Disorder (OCD) is characterized by disturbing and unwanted thoughts as well as repetitive and time-consuming behaviors that interfere with performance. Cognitive Behavior Therapy (CBT) has shown to have beneficial effects on reducing OCD symptoms as the first line of treatment. Moreover, Virtual Reality (VR) has been a more feasible and accessible intervention for OCD in recent years. Regarding the point, the objective of this study was to evaluate the effectiveness of virtual reality exposure and response prevention (VRERP) in the treatment of the OCD contamination subtype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total number of 36 adults with OCD-contamination subtype were registered and randomly assigned to the intervention and control groups. The intervention group received a 60-min CBT including a \u201ccontaminated\u201d virtual environment while the control group received CBT as a standardized treatment. Out of these, 29 patients completed the treatment in 12 weekly sessions. The patients completed the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Obsessive Beliefs Questionnaire-44(OBQ-44), and World Health Organization Disability Assessment Scale-2 (WHODAS-2) at week 0, week 12 and after 3\u2009months follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Based on the results of the repeated measure analysis of variances, the total score of obsession and compulsion subscales of Y-BOCS significantly decreased as a primary outcome in the intervention group (<jats:italic>F<\/jats:italic>\u00a0=\u200960.97, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001, partial eta squared\u2009=\u20090.82; <jats:italic>F<\/jats:italic>\u00a0=\u200920.46, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001, partial eta squared\u2009=\u20090.61; <jats:italic>F<\/jats:italic>\u00a0=\u200929.57, P\u2009&lt;\u20090.001, partial eta squared\u2009=\u20090.69; respectively). The total score of BDI-II and BAI was reduced in both groups but there was no significant difference between them (BDI-II: <jats:italic>F<\/jats:italic>\u00a0=\u20090.54, <jats:italic>P<\/jats:italic>\u00a0=\u20090.47, partial eta squared\u2009=\u20090.02; BAI: <jats:italic>F<\/jats:italic>\u00a0=\u20093.12, <jats:italic>P<\/jats:italic>\u00a0=\u20090.06, partial eta squared\u2009=\u20090.19). However, there was a significant difference in the OBQ-44 (<jats:italic>F<\/jats:italic>\u00a0=\u200916.78, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001, partial eta squared\u2009=\u20090.56) and the total WHODAS-2 score between the groups (<jats:italic>F<\/jats:italic>\u00a0=\u200914.64, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001, partial eta squared\u2009=\u20090.53).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study demonstrated the effectiveness of VRERP in the treatment of the OCD-contamination subtype. Therefore, VRERP can be used in CBT as an alternative exposure tool.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Iranian Registry of Clinical Trials, IRCT ID: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.irct.ir\/trial\/54374\">IRCT20210214050353N1<\/jats:ext-link>, Registered on 16\/10\/2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-022-04402-3","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T13:04:12Z","timestamp":1669640652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8315-1370","authenticated-orcid":false,"given":"Razieh","family":"Javaherirenani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4565-9688","authenticated-orcid":false,"given":"Seyede Salehe","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-3441","authenticated-orcid":false,"given":"Mohammadreza","family":"Shalbafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4444-4530","authenticated-orcid":false,"given":"Ahmad","family":"Ashouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-237X","authenticated-orcid":false,"given":"Abbas Ramezani","family":"Farani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"4402_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.janxdis.2021.102404","volume":"80","author":"AJ Cullen","year":"2021","unstructured":"Cullen AJ, Dowling NL, Segrave R, Carter A, Y\u00fccel M. Exposure therapy in a virtual environment: validation in obsessive compulsive disorder. J Anxiety Disord. 2021;80:1\u20139. https:\/\/doi.org\/10.1016\/j.janxdis.2021.102404.","journal-title":"J Anxiety Disord"},{"issue":"1","key":"4402_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0005-7967(95)00047","volume":"34","author":"SG Ball","year":"1996","unstructured":"Ball SG, Baer L, Otto MW. Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative review. Behav Res Ther. 1996;34(1):47\u201351. https:\/\/doi.org\/10.1016\/0005-7967(95)00047.","journal-title":"Behav Res Ther"},{"issue":"3","key":"4402_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cpr.2004.04.003","volume":"24","author":"D McKay","year":"2004","unstructured":"McKay D, Abramowitz JS, Calamari JE, Kyrios M, Radomsky A, Sookman D, et al. A critical evaluation of obsessive-compulsive disorder subtypes: symptoms versus mechanisms. Clin Psychol Rev. 2004;24(3):283\u2013313. https:\/\/doi.org\/10.1016\/j.cpr.2004.04.003.","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"4402_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5817\/CP2021-1-7","volume":"15","author":"M Inozu","year":"2021","unstructured":"Inozu M, \u00c7elikcan U, Trak E, \u00dcz\u00fcmc\u00fc E, Nergiz H. Assessment of virtual reality as an anxiety and disgust provoking tool: the use of VR exposure in individuals with high contamination fear. Cyberpsychol: J Psychosoc Res Cyberspace. 2021;15(1):7. https:\/\/doi.org\/10.5817\/CP2021-1-7.","journal-title":"Cyberpsychol: J Psychosoc Res Cyberspace"},{"key":"4402_CR5","unstructured":"Rachman S, Shafran R. Cognitive behavioral features of obsessive\u2013compulsive disorder. In: Swinson RP, Antony MM, Rachman S, Richter MA, editors. Obsessive\u2013compulsive disorder: theory, research, and treatment: Guilford Press; 1998. p. 51\u201378."},{"issue":"1","key":"4402_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mp.2008.94","volume":"15","author":"AM Ruscio","year":"2010","unstructured":"Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive\u2013compulsive disorder in the national comorbidity survey replication. Mol Psychiatry. 2010;15(1):53\u201363. https:\/\/doi.org\/10.1038\/mp.2008.94.","journal-title":"Mol Psychiatry"},{"key":"4402_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.comppsych.2016.10.004","volume":"73","author":"A Asnaani","year":"2016","unstructured":"Asnaani A, Kaczkurkin AN, Alpert E, McLean CP, Simpson HB, Foa EB. The effect of treatment on quality of life and functioning in OCD. Compr Psychiatry. 2016;73:7\u201314. https:\/\/doi.org\/10.1016\/j.comppsych.2016.10.004.","journal-title":"Compr Psychiatry"},{"issue":"8","key":"4402_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","volume":"3","author":"P Skapinakis","year":"2016","unstructured":"Skapinakis P, Caldwell DM, Hollingworth W, et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2016;3(8):730\u20139. https:\/\/doi.org\/10.1016\/S2215-0366(16)30069-4.","journal-title":"Lancet Psychiatry"},{"issue":"13","key":"4402_CR9","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jama.2017.2200","volume":"317","author":"ME Hirschtritt","year":"2017","unstructured":"Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA. 2017;317(13):1358\u201367. https:\/\/doi.org\/10.1001\/jama.2017.2200.","journal-title":"JAMA"},{"issue":"3","key":"4402_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.psychres.2014.11.058","volume":"225","author":"D McKay","year":"2015","unstructured":"McKay D, Sookman D, Neziroglu F, Wilhelm S, Stein DJ, Kyrios M, et al. Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder. Psychiatry Res. 2015;225(3):236\u201346. https:\/\/doi.org\/10.1016\/j.psychres.2014.11.058.","journal-title":"Psychiatry Res"},{"key":"4402_CR11","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.4103\/psychiatry.IndianJPsychiatry_516_18","volume":"61","author":"DM Hezel","year":"2019","unstructured":"Hezel DM, Simpson HB. Exposure and response prevention for obsessive compulsive disorder: a review and new directions. Indian J Psychiatry. 2019;61:S85\u201392. https:\/\/doi.org\/10.4103\/psychiatry.IndianJPsychiatry_516_18.","journal-title":"Indian J Psychiatry"},{"issue":"3","key":"4402_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1469-8986.1983.tb02163.x","volume":"20","author":"JM Arabian","year":"1983","unstructured":"Arabian JM, Furedy JJ. Individual differences in imagery ability and Pavlovian heart rate decelerative conditioning. Psychophysiology. 1983;20(3):325\u201331. https:\/\/doi.org\/10.1111\/j.1469-8986.1983.tb02163.x.","journal-title":"Psychophysiology"},{"issue":"7","key":"4402_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fpsyt.2016.00099","volume":"13","author":"M Laforest","year":"2016","unstructured":"Laforest M, Bouchard S, Boss\u00e9 J, Mesly O. Effectiveness of in virtuo exposure and response prevention treatment using cognitive-behavioral therapy for obsessive-compulsive disorder: a study based on a single-case study protocol. Front Psychiatry. 2016;13(7):99. https:\/\/doi.org\/10.3389\/fpsyt.2016.00099.","journal-title":"Front Psychiatry"},{"issue":"7","key":"4402_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/070674370605100702","volume":"51","author":"JS Abramowitz","year":"2006","unstructured":"Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatr. 2006;51(7):407\u201316. https:\/\/doi.org\/10.1177\/070674370605100702.","journal-title":"Can J Psychiatr"},{"key":"4402_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cpr.2015.06.003","volume":"40","author":"LG \u00d6st","year":"2015","unstructured":"\u00d6st LG, Havnen A, Hansen B, Kvale G. Cognitive behavioral treatments of obsessive\u2013compulsive disorder. A systematic review and meta-analysis of studies published 1993\u20132014. Clin Psychol Rev. 2015;40:156\u201369. https:\/\/doi.org\/10.1016\/j.cpr.2015.06.003.","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"4402_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1192\/bjp.pb.116.193300","volume":"210","author":"L Gega","year":"2017","unstructured":"Gega L. The virtues of virtual reality in exposure therapy. Br J Psychiatry. 2017;210(4):245\u20136. https:\/\/doi.org\/10.1192\/bjp.pb.116.193300.","journal-title":"Br J Psychiatry"},{"issue":"7","key":"4402_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1109\/MC.1995.10085","volume":"28","author":"DR Pratt","year":"1995","unstructured":"Pratt DR, Zyda M, Kelleher K. Virtual reality: in the mind of the beholder. Computer. 1995;28(7):17\u20139. https:\/\/doi.org\/10.1109\/MC.1995.10085.","journal-title":"Computer."},{"issue":"3","key":"4402_CR18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.chb.2007.03.006","volume":"24","author":"J Bush","year":"2008","unstructured":"Bush J. Viability of virtual reality exposure therapy as a treatment alternative. Comput Hum Behav. 2008;24(3):1032\u201340. https:\/\/doi.org\/10.1016\/j.chb.2007.03.006.","journal-title":"Comput Hum Behav"},{"key":"4402_CR19","first-page":"37","volume":"99","author":"C Botella","year":"2004","unstructured":"Botella C, Quero S, Ba\u00f1os RM, Perpi\u00f1\u00e1 C, Garcia-Palacios A, Riva G. Virtual reality and psychotherapy. Stud Health Technol Inform. 2004;99:37\u201354.","journal-title":"Stud Health Technol Inform."},{"key":"4402_CR20","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2147\/NDT.S89542","volume":"11","author":"C Botella","year":"2015","unstructured":"Botella C, Serrano B, Ba\u00f1os RM, Garcia-Palacios A. Virtual reality exposure-based therapy for the treatment of post-traumatic stress disorder: a review of its efficacy, the adequacy of the treatment protocol, and its acceptability. Neuropsychiatr Dis Treat. 2015;11:2533\u201345. https:\/\/doi.org\/10.2147\/NDT.S89542.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"4402_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/cpb.2007.9962","volume":"10","author":"A Garcia-Palacios","year":"2007","unstructured":"Garcia-Palacios A, Botella C, Hoffman H, Fabregat S. Comparing acceptance and refusal rates of virtual reality exposure vs. in vivo exposure by patients with specific phobias. CyberPsychology Behav. 2007;10(5):722\u20134. https:\/\/doi.org\/10.1089\/cpb.2007.9962.","journal-title":"CyberPsychology Behav"},{"key":"4402_CR22","first-page":"59","volume":"44","author":"MM North","year":"1997","unstructured":"North MM, North SM, Coble JR. Virtual reality therapy: an effective treatment for psychological disorders. Stud Health Technol Inform. 1997;44:59\u201370.","journal-title":"Stud Health Technol Inform"},{"key":"4402_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fict.2016.00018","volume":"3","author":"M Laforest","year":"2016","unstructured":"Laforest M, Bouchard S, Cretu AM, Mesly O. Inducing an anxiety response using a contaminated virtual environment: validation of a therapeutic tool for obsessive\u2013compulsive disorder. Frontiers ICT. 2016;3:18. https:\/\/doi.org\/10.3389\/fict.2016.00018.","journal-title":"Frontiers ICT"},{"key":"4402_CR24","doi-asserted-by":"publisher","first-page":"100518","DOI":"10.1016\/j.jocrd.2020.100518","volume":"25","author":"M Inozu","year":"2020","unstructured":"Inozu M, Celikcan U, Akin B, Ciek NM. The use of virtual reality exposure for reducing contamination fear and disgust: can VR be an effective alternative exposure technique to in vivo? J Obsessive-Compulsive Relat Disord. 2020;25:100518. https:\/\/doi.org\/10.1016\/j.jocrd.2020.100518.","journal-title":"J Obsessive-Compulsive Relat Disord"},{"key":"4402_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.fjpsy.2020.02.004","volume":"1","author":"N Benzina","year":"2020","unstructured":"Benzina N, Morgi\u00e8ve M, Euvrard M, Dos Santosb JFA, Pelissolo A, Mallet L. Personalised 360 video exposure therapy for the treatment of obsessive-compulsive disorder: a single case study. Fr J Psychiatry. 2020;1:31\u20138. https:\/\/doi.org\/10.1016\/j.fjpsy.2020.02.004.","journal-title":"Fr J Psychiatry"},{"issue":"1","key":"4402_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5944\/rppc.vol.19.num.1.2014.12981","volume":"19","author":"A Belloch","year":"2014","unstructured":"Belloch A, Cabedo E, Carri\u00f3 C, Lozano-Quilis JA, Gil-G\u00f3mez JA, Gil-G\u00f3mez H. Virtual reality exposure for OCD: is it feasible? J Psychopathol Clin Psychol. 2014;19(1):37\u201344. https:\/\/doi.org\/10.5944\/rppc.vol.19.num.1.2014.12981.","journal-title":"J Psychopathol Clin Psychol"},{"issue":"6","key":"4402_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1055\/s-0043-118665","volume":"51","author":"P Vl\u010dek","year":"2018","unstructured":"Vl\u010dek P, Polak J, Brunovsky M, Hora\u010dek J. Role of glutamatergic system in obsessive-compulsive disorder with possible therapeutic implications. Pharmacopsychiatry. 2018;51(6):229\u201342. https:\/\/doi.org\/10.1055\/s-0043-118665.","journal-title":"Pharmacopsychiatry."},{"key":"4402_CR28","unstructured":"Leahy RL, Holland SJ, McGinn LK. Treatment plans and interventions for depression and anxiety disorders. Translated by Akbari M and Chiniforoushan M. Tehran: Arjmand Pub;\u00a02012."},{"issue":"6","key":"4402_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1055\/s-0043-120268","volume":"51","author":"A Modarresi","year":"2018","unstructured":"Modarresi A, Sayyah M, Razooghi S, Eslami K, Javadi M, Kouti L. Memantine augmentation improves symptoms in serotonin reuptake inhibitor- refractory obsessive-compulsive disorder: a randomized controlled trial. Pharmacopsychiatry. 2018;51(6):263\u20139. https:\/\/doi.org\/10.1055\/s-0043-120268.","journal-title":"Pharmacopsychiatry."},{"issue":"4","key":"4402_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00213-013-3067-z","volume":"228","author":"M Haghighi","year":"2013","unstructured":"Haghighi M, Jahangard L, Mohammad-Beigi H, Bajoghli H, Hafezian H, Rahimi A, et al. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). Psychopharmacology. 2013;228(4):633\u201340. https:\/\/doi.org\/10.1007\/s00213-013-3067-z.","journal-title":"Psychopharmacology"},{"issue":"5","key":"4402_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/YIC.0000000000000321","volume":"35","author":"F Yousefzadeh","year":"2020","unstructured":"Yousefzadeh F, Sahebolzamani E, Sadri A, Mortezaei A, Aqamolaei A, Mortazavi SH, et al. 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a doubleblind randomized trial with placebo control. Int Clin Psychopharmacol. 2020;35(5):254\u201362. https:\/\/doi.org\/10.1097\/YIC.0000000000000321.","journal-title":"Int Clin Psychopharmacol"},{"issue":"11","key":"4402_CR32","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown obsessive-compulsive scale: I. development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006\u201311. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110048007.","journal-title":"Arch Gen Psychiatry"},{"key":"4402_CR33","first-page":"297","volume":"17","author":"S Rajezi Esfahani","year":"2012","unstructured":"Rajezi Esfahani S, Motaghipour Y, Kamkari K, Zahiredin A, Janbozorgi M. Reliability and validity of the Persian version of the Yale-Brown obsessive \u2013compulsive scale (Y-BOCS). Iran J Psychiatry Clin Psychol. 2012;17:297\u2013303.","journal-title":"Iran J Psychiatry Clin Psychol"},{"issue":"2","key":"4402_CR34","first-page":"490","volume":"78","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio. 1996;78(2):490\u20138.","journal-title":"San Antonio"},{"issue":"4","key":"4402_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/da.20070","volume":"21","author":"H Ghassemzadeh","year":"2005","unstructured":"Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian-language version of the Beck depression inventory-second edition: BDI-II-Persian. Depress Anxiety. 2005;21(4):185\u201392. https:\/\/doi.org\/10.1002\/da.20070.","journal-title":"Depress Anxiety"},{"issue":"2","key":"4402_CR36","first-page":"136","volume":"66","author":"H Kaviani","year":"2008","unstructured":"Kaviani H, Mousavi A. Psychometric properties of the Persian version of Beck anxiety inventory (BAI). Tehran Univ Med J. 2008;66(2):136\u201340.","journal-title":"Tehran Univ Med J"},{"issue":"1","key":"4402_CR37","first-page":"23","volume":"6","author":"G Shams","year":"2004","unstructured":"Shams G, Karamghadiri N, Esmaeli Torkanbori Y, Ebrahimkhani N. Validation and reliability assessment of the Persian version of obsessive beliefs Questionnaire-44. Adv Cogn Sci. 2004;6(1):23\u201336.","journal-title":"Adv Cogn Sci"},{"key":"4402_CR38","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. Translated by Rezaee F et al. Tehran: Arjmand Pub;\u00a02013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"4402_CR39","unstructured":"Zahiroddin A. Validity and reliability of World Health Organization disability assessment schedule 2 for mental disorders.\u00a0Iran J Psychiatry Clin Psychol.\u00a02017;22(3):0\u20130."},{"issue":"147","key":"4402_CR40","first-page":"126","volume":"27","author":"O Amani","year":"2017","unstructured":"Amani O, Mazaheri MA, Nejati V, Shamsian S. Effectiveness of cognitive rehabilitation in executive functions (attention and working memory) in adolescents survived from acute lymphoblastic leukemia with a history of chemotherapy: a randomized clinical trial. J Mazandaran Univ Med Sci. 2017;27(147):126\u201338.","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"27","key":"4402_CR41","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1177\/154193120104502709","volume":"45","author":"BK Jaeger","year":"2001","unstructured":"Jaeger BK, Mourant RR. Comparison of simulator sickness using static and dynamic walking simulators. Proc Hum Factors Ergon Soc Annu Meet. 2001;45(27):1896\u2013900. https:\/\/doi.org\/10.1177\/154193120104502709.","journal-title":"Proc Hum Factors Ergon Soc Annu Meet"},{"issue":"2","key":"4402_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.displa.2007.09.009","volume":"29","author":"PA Howarth","year":"2008","unstructured":"Howarth PA, Hodder SG. Characteristics of habituation to motion in a virtual environment. Displays. 2008;29(2):117\u201323. https:\/\/doi.org\/10.1016\/j.displa.2007.09.009.","journal-title":"Displays."},{"issue":"6","key":"4402_CR43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1162\/pres.15.6.699","volume":"15","author":"JN Bailenson","year":"2006","unstructured":"Bailenson JN, Yee N. A longitudinal study, of task performance, head movements, subjective report, simulator sickness, and transformed social interaction in collaborative virtual environments. Presence-Teleoperators Virtual Environ. 2006;15(6):699\u2013716.","journal-title":"Presence-Teleoperators Virtual Environ"},{"key":"4402_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-8023-6","volume-title":"Advances in virtual reality and anxiety disorders","author":"BK Wiederhold","year":"2014","unstructured":"Wiederhold BK, Bouchard S. Advances in virtual reality and anxiety disorders. New York: Springer press; 2014."},{"issue":"1","key":"4402_CR45","first-page":"111","volume":"14","author":"M Soleimani","year":"2016","unstructured":"Soleimani M, Ahmadi K, Mohammadi A. Virtual reality exposure therapy in anxiety disorders and posttraumatic stress disorder: a systematic review of literature. J Res Behav Sci. 2016;14(1):111\u201324.","journal-title":"J Res Behav Sci"},{"issue":"1","key":"4402_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpsychires.2012.08.020","volume":"47","author":"BO Olatunji","year":"2013","unstructured":"Olatunji BO, Davis ML, Powers MB, Smits JA. Cognitive-behavioral therapy for obsessive-compulsive disorder: a meta-analysis of treatment outcome and moderators. J Psychiatr Res. 2013;47(1):33\u201341. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.08.020.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"4402_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.29252\/mcs.4.1.49","volume":"4","author":"M Aliakbari","year":"2017","unstructured":"Aliakbari M, Alipor A, Ebrahimimoghadam H, Fekraty M. The effect of virtual reality (VR) on psychological disorders in Cancer cases. Mil Caring Sci. 2017;4(1):49\u201357.","journal-title":"Mil Caring Sci"},{"key":"4402_CR48","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.compbiomed.2011.12.010","volume":"42","author":"K Kim","year":"2012","unstructured":"Kim K, Roh D, Kim SI, Kim CH. Provoked arrangement symptoms in obsessive\u2013compulsive disorder using a virtual environment: a preliminary report. Comput Biol Med. 2012;42:422\u20137. https:\/\/doi.org\/10.1016\/j.compbiomed.2011.12.010.","journal-title":"Comput Biol Med"},{"issue":"3","key":"4402_CR49","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1037\/0090-5550.46.3.296","volume":"46","author":"MT Schultheis","year":"2001","unstructured":"Schultheis MT, Rizzo A. The application of virtual reality technology in rehabilitation. Rehabil Psychol. 2001;46(3):296\u2013311. https:\/\/doi.org\/10.1037\/0090-5550.46.3.296.","journal-title":"Rehabil Psychol"},{"issue":"14","key":"4402_CR50","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1017\/S003329171700040X","volume":"47","author":"D Freeman","year":"2017","unstructured":"Freeman D, Reeve S, Robinson A, Ehlers A, Clark D, Spanlang B, et al. Virtual reality in the assessment, understanding, and treatment of mental health disorders. Psychol Med. 2017;47(14):2393\u2013400. https:\/\/doi.org\/10.1017\/S003329171700040X.","journal-title":"Psychol Med"},{"issue":"2","key":"4402_CR51","first-page":"187","volume":"47","author":"J Cox","year":"1994","unstructured":"Cox J, Westbrook RF. The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesic responses in the rat. Q J Exp Psychol B Comp Physiol Psychol. 1994;47(2):187\u2013210.","journal-title":"Q J Exp Psychol B Comp Physiol Psychol"},{"issue":"1","key":"4402_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1176\/appi.ajp.162.1.151","volume":"162","author":"EB Foa","year":"2005","unstructured":"Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatr. 2005;162(1):151\u201361. https:\/\/doi.org\/10.1176\/appi.ajp.162.1.151.","journal-title":"Am J Psychiatr"},{"issue":"5","key":"4402_CR53","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hipo.10099","volume":"12","author":"KA Goosens","year":"2002","unstructured":"Goosens KA, Maren S. Long-term potentiation as a substrate for memory: evidence from studies of amygdaloid plasticity and Pavlovian fear conditioning. Hippocampus. 2002;12(5):592\u20139. https:\/\/doi.org\/10.1002\/hipo.10099.","journal-title":"Hippocampus."},{"key":"4402_CR54","unstructured":"Ayuos-Mateos JL.\u00a0Global Burden of Obsessive Compulsive Disorders in the Year 2000. GBD 2000 Working Paper. BD 2000 Working Paper. Geneva: WHO;\u00a02002."},{"issue":"2","key":"4402_CR55","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1037\/0033-295X.84.2.191","volume":"84","author":"A Bandura","year":"1977","unstructured":"Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191.","journal-title":"Psychol Rev"},{"key":"4402_CR56","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/cpp.2623","volume":"28","author":"K Meyerbr\u00f6ker","year":"2021","unstructured":"Meyerbr\u00f6ker K, Morina M. The use of virtual reality in assessment and treatment of anxiety and related disorders. Clin Psychol Psychother. 2021;28:466\u201376. https:\/\/doi.org\/10.1002\/cpp.2623.","journal-title":"Clin Psychol Psychother"},{"key":"4402_CR57","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/B978-0-12-397045-9.00266-4","volume":"2","author":"SA Steinman","year":"2016","unstructured":"Steinman SA, Wootton BM, Tolin DF. Exposure therapy for anxiety disorders. Encyclopedia Mental Health. 2016;2:186\u201391. https:\/\/doi.org\/10.1016\/B978-0-12-397045-9.00266-4.","journal-title":"Encyclopedia Mental Health"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04402-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04402-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04402-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T07:04:12Z","timestamp":1669705452000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04402-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4402"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04402-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"28 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by the Research Ethics Committee of the Iran University of Medical Sciences (IR.IUMS.REC.1400.595) and all methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all participants. Patients were informed that their participation was a voluntary activity and that they had the right to leave the study at any time with no negative effect on their treatment. They were also informed about confidentiality. The trial was registered at the Iranian Registry of Clinical Trials on 16\/10\/2021 (; IRCT ID: IRCT20210214050353N1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"740"}}